Company Filing History:
2 out of 123 
2 out of 8 
Years Active: 2017-2021
Title: Shamseer Kulangara Kandi: Innovator in Pharmaceutical Sciences
Introduction
Shamseer Kulangara Kandi is a notable inventor based in Delhi, India. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on aminoquinoline derivatives. With a total of 2 patents, his research focuses on developing compounds that can aid in diagnosing and treating various medical conditions.
Latest Patents
Kandi's latest patents include groundbreaking work on aminoquinoline and aminoacridine based hybrids. These patents describe pharmaceutical compositions and medicaments that incorporate these hybrids. The methods outlined in his patents are aimed at diagnosing and treating infections, neurodegenerative diseases, inflammation, and disorders treatable with dopamine agonists, such as restless leg syndrome. His research holds promise for advancing therapeutic options in these critical areas.
Career Highlights
Throughout his career, Shamseer Kulangara Kandi has worked with esteemed organizations such as the Mclean Hospital Corporation and the University of Delhi. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in pharmaceutical research.
Collaborations
Kandi has collaborated with notable colleagues, including Diwan S Rawat and Sunny Manohar. These partnerships have further enriched his research and innovation efforts, leading to impactful developments in the pharmaceutical sector.
Conclusion
Shamseer Kulangara Kandi's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and diagnostics.